REMINGTON MODEL 12 SERIAL NUMBER 777499 PDF

C12N15/11- DNA or RNA fragments Modified forms thereof Non-coding nucleic acids having a biological activity.plasmids, or their isolation, preparation or purification Use of hosts therefor C12N15/00- Mutation or genetic engineering DNA or RNA concerning genetic engineering, vectors, e.g.C12N- MICROORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA.C12- BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION OR GENETIC ENGINEERING.0 Chemical compound 0.000 description 1.Priority to US15/232,493 priority patent/US10179912B2/en Priority to US16/201,951 priority patent/US10913946B2/en Priority to US17/131,130 priority patent/US20210108204A1/en Status Abandoned legal-status Critical Current Links CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: DE VISSER, PETER CHRISTIAN, VAN DEUTEKOM, JUDITH CHRISTINA THEODORA Publication of US20150045413A1 publication Critical patent/US20150045413A1/en Assigned to BIOMARIN TECHNOLOGIES B.V. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Application filed by PROSENSA TECHNOLOGIES BV filed Critical PROSENSA TECHNOLOGIES BV Priority to US14/444,244 priority Critical patent/US20150045413A1/en Assigned to PROSENSA TECHNOLOGIES B.V. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation First worldwide family litigation filed litigation Critical (A1) 'Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License. Original Assignee PROSENSA TECHNOLOGIES BV Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Abandoned Application number US14/444,244 Inventor Peter Christian De Visser Judith Christina Theodora Van Deutekom Current Assignee (The listed assignees may be inaccurate.

REMINGTON MODEL 12 SERIAL NUMBER 777499 PDF

Google Patents RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophyĭownload PDF Info Publication number US20150045413A1 US20150045413A1 US14/444,244 US201414444244A US2015045413A1 US 20150045413 A1 US20150045413 A1 US 20150045413A1 US 201414444244 A US201414444244 A US 201414444244A US 2015045413 A1 US2015045413 A1 US 2015045413A1 Authority US United States Prior art keywords seq oligonucleotide nucleotides fragment represented Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US20150045413A1 - RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy US20150045413A1 - RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy

Remington model 12 serial number 777499